J&J says its one-shot Covid vaccine is 72% effective in the U.S., but less potent in other regions
January 29, 2021 at 08:00 AM EST
The Covid vaccine was well tolerated, with no significant safety concerns related to the vaccine reported, J&J said. There were also no reports of anaphylaxis.